[Skip to Navigation]
January 1969

Congenital Hyperuricemia: An Inborn Error of Purine Metabolism Associated With Psychomotor Retardation, Athetosis, and Self-Mutilation

Author Affiliations

New York
From the departments of psychiatry and neurology (Dr. Berman), and pediatrics (Dr. Dancis), New York University Medical Center and the Sloan-Kettering Institute for Cancer Research (Dr. Balis). After April 1, 1969, Dr. Berman will be at Children's Hospital of Philadelphia, Philadelphia.

Arch Neurol. 1969;20(1):44-53. doi:10.1001/archneur.1969.00480070054006

RESENT reports have established the existence of a sex-linked, recessive inborn error of purine metabolism in which hyperuricemia and hyperuricosuria are associated with a distinctive clinical syndrome.1-6 Stunting of growth, retardation of mental and motor development, choreoathetosis, generalized spasticity, and compulsive selfmutilation characterize the clinical defect.3-6 The metabolic abnormalities have been attributed to a deficiency of the enzyme inosinate phosphoribosy pyrophosphate transferase (IMP:PRPP transferase).7 This enzyme mediates the conversion of hypoxanthine to inosinate (hypoxanthine ribosylphosphate), a reaction that permits the reutilization of hypoxanthine for nucleotide synthesis. Since hypoxanthine cannot be reutilized in patients with the disease, whatever hypoxan-thine is formed is either excreted or further catabolized to xanthine and uric acid. The hyperuricemia and hyperuricosuria in these patients also reflect a marked increase in de novo purine synthesis associated with an exceedingly rapid turnover of purine nucleotides.3

In the present report, the results of

Add or change institution